Bioelectric Medicine Development Summit
With investments pouring in and approvals on the rise, the bioelectric world is booming! The only sensing-enabled system is now on the market following the FDA’s recent approval of Medtronic’s DBS system and $3.7 billion has been put into Boston Scientific’s acquisition of Axonics to further advance sacral neuromodulation therapy.
As the only industry-led forum for experts developing medical grade neurostimulation devices, the Bioelectric Medicine Development Summit (Boston | June 4-6) is dedicated to bringing bioelectric medicine experts together to share cutting-edge insights in streamlining neuromodulation device approval from proof of concept to regulatory strategy.
Be the first to see the brand-new Event Guide with our star speaker faculty here: https://ter.li/9en149.
This industry dedicated meeting will unite 80+ neurostimulation experts from LivaNova, FDA, Boomerang Medical, Axonics, NeuSpera, Sinaptica Therapeutics, Saluda Medical, SPR Therapeutics and many more to discover novel strategies in obtaining funding, shortening clinical trials, approaching regulatory bodies, and overcoming reimbursement barriers.
Find out more here: https://ter.li/9en149.